New specification for steviol glycoside under evaluation by FSANZ
Australia
Aug 24, 2021
FSANZ is evaluating approval of a new specification for the steviol glycoside, rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract. Bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.
For further information (in English), click on the Link
9 new substances authorized for use as food and as ingredients in traditional Chinese medicine
China
Nov 22, 2023
Update of the Novel Food Catalogue
European Union
Nov 20, 2023
D-allulose Under Evalutation as Novel Food
Australia
Nov 10, 2023
Sodium salt of 6′-sialyllactose authorized as a novel food
European Union
Oct 24, 2023
3-fucosyl-lactose authorized as novel food
European Union
Oct 24, 2023
Amended conditions of use for novel food Partially Defatted Chia Seed (Salvia hispanica) Powders
European Union
Oct 24, 2023
FSAZN calls for submission on processing aid, new ingredients and GMOs
Australia
Oct 20, 2023
Corrections to language errors in EU list of novel foods
European Union
Oct 16, 2023
New approved ingredients for Health Foods
China
Oct 11, 2023
Changes in the entry into force of regulation on Liquid Mycelium Culture Powder
Taiwan
Oct 09, 2023
2′-FL from a GMO strain of E. coli may be soon authorized in infant and toddler formulas
Canada
Oct 05, 2023
EFSA to develop structured database on novel food information
European Union
Sep 08, 2023
Proposal on the use of insects as novel foods
Romania
Sep 07, 2023
New food substances under review
China
Aug 14, 2023
Amended conditions of use of novel food astaxanthin-rich oleoresin
European Union
Aug 03, 2023
